Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Resmed, a leader in health technology focused on sleep and breathing, announced the retirement of longtime CFO Brett Sandercock effective May 4, 2026. Aaron Bloomer, formerly CFO at Exact Sciences, will succeed him. The company reiterated its fiscal 2026 financial outlook, signaling stable operational expectations moving forward.